|

Interleukin-2 (IL2) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: IL2

Pipeline

Phase 1: 1

Top Sponsors

  • H. Lee Moffitt Cancer Center and Research Institute1

Indications

  • Recurrent Non-small Cell Lung Cancer1
  • Stage IV Non-small Cell Lung Cancer1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Tampa, Florida1 trial

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Moffitt Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.